Qiming Venture Partners

Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Shanghai Biotree biotech Co., Ltd. engages in the development of life science research technology application. The company application is used for sample testing, big data analysis, and technical product development in the field of life sciences, as well as to provides professional services. It serves universities, research institutes, hospitals, and enterprises. The company was founded in 2013 and is based in Shanghai, China.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

AskGene Pharma is a biotechnology firm. It is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. It is unlocking the full therapeutic potential of cytokine molecules with their innovative smart kine prodrug platform. It overcomes a number of significant challenges, providing a clear pathway to a range of next-generation cytokine therapies. They provide safer and better medicines for saving patients’ lives. They are equipped with the most advanced R&D facilities.

ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed. Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.

GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design. Atom Semiconductor was founded in 2020.

Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China. The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology. The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005. ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

Eigen is applying the latest AI technologies to variety of business domains, making AI the center of thegravity in industrial evolutions.

CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

AI Prime is a life sciences company focused on developing oncology therapeutics targeting the growth and proliferation of cancer cells.

ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China. The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology. The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005. ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.

Eigen is applying the latest AI technologies to variety of business domains, making AI the center of thegravity in industrial evolutions.

Gaiya Environment is a scientific and innovative enterprise specializing in independent research and development of soil remediation technology and equipment. Based on the industrialization and application of scientific research results and the core of independent technological innovation, the company adheres to the strategy of providing customers with one-stop solutions from front-end field to back-end repair through national network layout. Gaiya Environment was founded in 2012 and is based in Suzhou in Jiangsu, China.

SGEET is a high-tech enterprise that specializes in the disposal of organic waste and the remediation of contaminated sites.

Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

CETA is an environmental test and analysis company.

Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China. The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology. The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005. ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.

Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China. The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology. The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005. ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.

Supplier of analytical software trading tools intended to provide accurate, real-time market data. The company's technical analysis and fundamental information tool enables most energy companies and large agricultural trading firms to manage, filter and quickly analyze pricing, trends and news, that is crucial to making informed and profitable trading decisions. It also provides server and middleware tools, as well as a rich set of web services for customers integrating financial information and analysis of their enterprise-wide systems.

Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

Ants Technology

Ants Technology

Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.

Alltech Medical Systems is a Chinese company that specializes in medical imaging technologies and solutions, particularly in the development of magnetic resonance imaging (MRI) systems and other advanced diagnostic equipment. Its primary operational hubs are located in Cleveland, USA, and Chengdu, China. The company offers a range of products, including a 1.5 T magnetic resonance system that features a multichannel data acquisition system for real-time imaging and advanced RF coils. These innovations support a variety of clinical applications and incorporate intelligent graphical user interfaces for streamlined scanning workflows. Alltech Medical Systems also develops other imaging technologies such as X-ray computed tomography, digital X-ray systems, color Doppler ultrasound, and PET-MR. With a management and technology team comprised of professionals with extensive experience in medical imaging, the company has secured over 100 international patents in the field. It aims to enhance medical imaging services in hospitals across China by integrating Internet and artificial intelligence technologies into its offerings.